---
figid: PMC8958553__nihms-1761638-f0001
figtitle: AKI and CKD affect FGF23 via inflammatory, iron deficiency, anemia, and
  metabolic related pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8958553
filename: nihms-1761638-f0001.jpg
figlink: /pmc/articles/PMC8958553/figure/F1/
number: F1
caption: Downstream molecular targets are listed below each pathway. Arrows depict
  the effect of different pathways on FGF23 and dashed arrows show the feedback effect
  of FGF23. AKI, acute kidney injury; CKD, chronic kidney disease; IL-1, interleukin
  1; HIF, hypoxia inducible factor; IL-6, interleukin 6; STAT3, signal transducer
  and activator of transcription 3; ERRg, estrogen-related receptor g; TNFa, tumor
  necrosis factor a; TGFβ, transforming factor β; NFκB, nuclear factor κ-light-chain-enhancer
  of activated B cells; Orai1, calcium release-activated calcium channel protein 1;
  SOCE, store-operated calcium entry; LCN2, lipocalin 2; cAMP, cyclic adenosine monophosphate;
  G-CSF, granulocyte colony-stimulating factor; EPO, erythropoietin; G-3-P, glycerol-3-phosphate;
  LPA, lysophosphatidic acid; XLaS, extra-large G-protein subunit a; PKC, protein
  kinase C; AMPK, AMP-activated protein kinase; mTOR, mechanistic target of rapamycin
  kinase; IGF-1, insulin-like growth factor 1; FOXO1, forkhead box protein O1; Phos,
  phosphate.
papertitle: 'Regulation of FGF23: Beyond Bone.'
reftext: Petra Simic, et al. Curr Osteoporos Rep. ;19(6):563-573.
year: '2023'
doi: 10.1007/s11914-021-00703-w
journal_title: Current osteoporosis reports
journal_nlm_ta: Curr Osteoporos Rep
publisher_name: ''
keywords: Fibroblast growth factor 23 | phosphate | anemia | kidney injury | inflammation
  | metabolism
automl_pathway: 0.9339168
figid_alias: PMC8958553__F1
figtype: Figure
redirect_from: /figures/PMC8958553__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8958553__nihms-1761638-f0001.html
  '@type': Dataset
  description: Downstream molecular targets are listed below each pathway. Arrows
    depict the effect of different pathways on FGF23 and dashed arrows show the feedback
    effect of FGF23. AKI, acute kidney injury; CKD, chronic kidney disease; IL-1,
    interleukin 1; HIF, hypoxia inducible factor; IL-6, interleukin 6; STAT3, signal
    transducer and activator of transcription 3; ERRg, estrogen-related receptor g;
    TNFa, tumor necrosis factor a; TGFβ, transforming factor β; NFκB, nuclear factor
    κ-light-chain-enhancer of activated B cells; Orai1, calcium release-activated
    calcium channel protein 1; SOCE, store-operated calcium entry; LCN2, lipocalin
    2; cAMP, cyclic adenosine monophosphate; G-CSF, granulocyte colony-stimulating
    factor; EPO, erythropoietin; G-3-P, glycerol-3-phosphate; LPA, lysophosphatidic
    acid; XLaS, extra-large G-protein subunit a; PKC, protein kinase C; AMPK, AMP-activated
    protein kinase; mTOR, mechanistic target of rapamycin kinase; IGF-1, insulin-like
    growth factor 1; FOXO1, forkhead box protein O1; Phos, phosphate.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL1B
  - HIF1A
  - EPAS1
  - HIF3A
  - ARNT
  - ARNT2
  - BMAL1
  - IL6
  - TNF
  - STAT3
  - TGFB1
  - TGFB2
  - TGFB3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - LCN2
  - CSF3
  - ORAI1
  - EPO
  - TIMP1
  - EPX
  - FGF23
  - LPA
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - MTOR
  - FOXO1
  - IGF1
  - iron
  - G-3-P LPA
  - Low iron Anemia
---
